期刊文献+

胰岛素泵与皮下注射胰岛素对初诊2型糖尿病患者血管内皮功能的影响 被引量:8

Effects of Insulin Pumps and Subcutaneous Injection of Insulin on Vascular Endothelial Function of Type 2 Diabetes Mellitus Patients in Preliminary Diagnosis
下载PDF
导出
摘要 目的观察胰岛素泵(CSII)与常规皮下注射胰岛素(MSII)治疗对初诊2型糖尿病血管内皮功能的影响。方法将2012年6月—2013年5月住院的42例初诊2型糖尿病随机分为CSII组22例和MSII组20例,CSII组采用胰岛素泵连续皮下胰岛素注射,MSII组采用多次皮下胰岛素注射,观察两组血糖控制情况,采用血管外超声检测肱动脉血流介导的内皮依赖性血管舒张功能(FMD)和硝酸甘油介导的内皮非依赖性血管舒张功能(NMD),同时测定收缩期血流介导的血管达到最大舒张内径所需时间(T1)和硝酸甘油介导的血管达到最大舒张内径所需时间(T2)。结果治疗后7 d和14 d两组全天血糖值均低于治疗前,除CSII组晚餐前0.5 h和MSII组睡前血糖外,两组其余时间点血糖均低于治疗后7 d,CSII组除治疗后14 d晚餐前0.5 h血糖外,其他时间血糖水平均低于MSII组(P<0.01,P<0.05);两组FMD、NMD治疗后14 d均高于治疗前,T1、T2均短于治疗前;CSII组FMD、NMD高于MSII组,T1低于MSII组相同时间血糖(P<0.05)。结论 CSII较MSII治疗初诊2型糖尿病血糖控制更理想,可以更好的改善患者血管内皮功能。 Objective To observe the effects of continuous subcutaneous insulin infusion (CSII) by insulin pump and multiple subcutaneous insulin injection (MSII) on vascular endothelial function of type 2 diabetes mellitus patients in preliminary diagnosis. Methods A total of 42 type 2 diabetes mellitus inpatients in preliminary diagnosis during June 2012 and May 2013 were randomly divided into CSII group (n = 22) and MSII group (n = 20). CSII group was treated with con- tinuous subcutaneous insulin injection by insulin pump, while MSII group was treated with multiple subcutaneous insulin in- jection, and levels of controlling blood glucose in the two groups were observed. The flow-mediated dilation (FMD) and ni- troglycerin-mediated dilatation (NMD) in brachial artery were detected with ultrasonic testing, and the time (T1) of reac- hing the maximum dilatation diameter in blood vessels in systolic period and the time ( T2 ) of reaching the maximum dilata- tion diameter during NMD were detected synchronously. Results The values of all-day blood glucose 7 d and 14 d after treatment in two groups were significantly lower than those before treatment. The values of blood glucose on each time point in the two groups were lower than those of 7 d after treatment except for that of 30 min before dinner in CSII group and at bedtime in MSII group, the values of blood glucose 14 d after treatment on each time point in CSII group were significantly lower than those in MSII group except for that of 30 rain before dinner in CSII group (P 〈0. 01, P 〈0. 05) ; the values of FMD and NMD 14 d after treatment were significantly higher, and T1 and T2 were shorter than those before treatment in the two groups; compared with those in MSII group, values of FMD and NMD were higher and T1 was significantly shorter in CSII group (P 〈 0. 05 ). Conclusion CSII can better control blood glucose, and improve vascular endothelial function than MSII in treatment of type 2 diabetes mellitus patients in preliminary diagnosis.
出处 《解放军医药杂志》 CAS 2014年第4期74-76,83,共4页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
基金 国家科技重大专项子课题(2011ZX09307-001-08)
关键词 糖尿病 2型 胰岛素输注系统 内皮 血管 Diabetes mellitus, type 2 Insulin infusion system Endothelium, vascular
  • 相关文献

参考文献18

  • 1Herman W H. Diabetes epidemiology: guiding clinical and public health practice: the Kelly West Award Lec- ture, 2006 [ J ]. Diabetes Care, 2007,30 ( 7 ) : 1912- 1919.
  • 2Bonetti P O, Lerman L O, Lerman A. Endothelial dys- function: a marker of atheroscleroticrisk[ J]. Arterioscler Thromb Vasc Biol, 2003,23(2) :168-175.
  • 3中华医学会糖尿病分会.中国2型糖尿病防治指南[M].北京:北京大学医学出版社.2011.
  • 4Cohen G, Riahi Y, Alpert E, et al. The roles of hyper- glycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endo- thelial cell dysfunction in diabetes [ J]. Arch Physiol Bio- chem, 2007,113 ( 4-5 ) : 259-267.
  • 5Brunner H, Cockcroft J R, Deanfield J, et al. Endotheli- al function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Fac- tors of the European Society of Hypertension[ J]. J Hyper- tens, 2005,23 ( 2 ) :233-246.
  • 6Brownlee M. The pathobiology of diabetic complications: a unifying mechanism [ J ]. Diabetes, 2005,54 (6) :1615- 1625.
  • 7O1-Iora T R, Markos F, Wiernsperger N F, et al. Met- formin causes nitric oxide- mediated dilatation in a shorter time than insulin in the iliac artery of the anesthetized pig [ J ]. J C ardiovase Pharmacol, 2012,59 N ( 2 ) : 182-187.
  • 8Rey Valzacchi G J, Costanzo P R, Finger L A, et al. Addition of metformin to sildenafil treatment for erectile dysfunction in eugonadal nondiabetic men with insulin re- sistance. A prospective, randomized, double-blind pilot study[J]. J Androl, 2012,33(4) :608-614.
  • 9Petrica L, Vlad A, Petrica M, et al. Pioglitazone delays proximal tubule dysfunction and improves cerebral vessel endothelial dysfunction in normoalbuminuric people with type 2 diabetes mellitus [ J]. Diabetes Res Clin Pract, 2011,94( 1 ) :22-32.
  • 10陈彬,吕肖锋,刘福平.两种胰岛素应用方法治疗初诊2型糖尿病的疗效观察[J].中国热带医学,2010,10(7):889-889. 被引量:1

二级参考文献26

  • 1杨文英.如何选择不同的胰岛素治疗方案以提高胰岛素治疗的技巧[J].国际内分泌代谢杂志,2006,26(3):195-197. 被引量:62
  • 2朱旅云,杨少玲,田庆波,单巍,胡丽叶.胰岛素强化治疗对初诊2型糖尿病血管内皮功能的影响[J].白求恩军医学院学报,2006,4(4):197-199. 被引量:11
  • 3[2]Li Y,Xu W,Liao Z,et al.Induction of long-term glycemic control in newly diagnosed type 2 diabetes patients is associated with improvement of beta-cell function.Diabetes Care,2004,27(11):2597-2602.
  • 4[3]Haffner SM,Miettinen H,Stern MP.The homeostasis model in the San Antonio Heart Study.Diabetes Care,1997,20(7):1087-1092.
  • 5[4]Pandit K,Muldopadhyay P.Insulin therapy-role beyond glucose control.J Indian Med Assoc,2004,102(10):572,574,576 passim.
  • 6[6]Basta G,Schmidt AM,De Caterina R.Advanced glycation end products and vascular inflammation:implications for accelerated atherosclerosis in diabetes.Cardiovasc Res,2004,63(4):582-592.
  • 7[7]Boyle JJ.Macrophage activation in atherosclerosis:pathogenesis and pharmacology of plaque rupture.Curr Vasc Pharmacol,2005,3(1):63-68.
  • 8[8]Woodman RJ,Chew GT,Watts GF.Mechanisms,significance and treatment of vascular dysfunction in type 2 diabetes mellitus:focus on lipidregulating therapy.Drugs,2005,65(1):31-74.
  • 9[9]Vehkavaara S,Yki Jarvinen H.3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes.Arterioscler Thromb Vasc Biol,2004,24(2):325-330.
  • 10Su Y,Liu XM,Sun YM,et al.Endothelial dysfunction in impaired fasting glycemia,impaired glucose tolerance,and type 2 diabetes mellitus[J].The American Journal of Cardiology,2008,102(4):497-498.

共引文献84

同被引文献54

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部